Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes

Abstract Background Anti-vascular endothelial growth factor (anti-VEGF) therapy is used for myopic choroidal neovascularization (mCNV). Patchy chorioretinal atrophy (pCRA) enlargement has been reported in mCNV cases associated with vision loss. Our aim was to compare the long-term effectiveness of a...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Meng-Tian Kang, Ningli Wang, Wenjun Xu, Mayinuer Yusufu, Wu Liu, Jiaxin Tian, Yue Qi
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2024-03-01
Σειρά:	BMC Ophthalmology
Θέματα:	Choroidal neovascularization Myopic maculopathy Anti-vascular endothelial growth factor Posterior scleral reinforcement
Διαθέσιμο Online:	https://doi.org/10.1186/s12886-024-03357-1
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!